Drug
Dfd 29
Dfd 29: highest development phase Phase 3, developed by Dr. Reddy's. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Dr. Reddy's
Trials
| Drug | Phase | Indication |
|---|---|---|
| DFD-29 NCT05343455 | Phase 3 | Papulopustular Rosacea |
| DFD-29 Extended Release Capsules (40 mg) NCT03340961 | Phase 2 | Rosacea |
Latest
No recent events.
Follow Dfd 29 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.